SSP International Services, Pharmaceutical Import Profile — Guyana (DGFT 2022–2026)

Name: SSP International Services, Pharmaceutical Import Records from India — 2 Products, $32.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SSP International Services, — Pharmaceutical Importer Profile (2026) | 2 Products, $32.2K Trade | TransData Nexus

SSP International Services,

Pharmaceutical Importer · Guyana · Brand Names & OTC Products Focus · $32.2K Total Trade · DGFT Verified

SSP International Services, is a pharmaceutical importer based in Guyana with a total trade value of $32.2K across 2 products in 1 therapeutic categories. Based on 31 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. SSP International Services, sources from 3 verified Indian suppliers, with Aashirwad Pharma International Private Limited accounting for 51.1% of imports.

SSP International Services, — Import Portfolio & Supplier Network

SSP International Services, import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to SSP International Services,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aashirwad Pharma International Private Limited	$660.7K	495	51.1%
Aashirwad Exports	$605.0K	383	46.8%
Aurochem Laboratories (india) Private Limited	$27.5K	7

What Formulations Does SSP International Services, Import?

Formulation	Value	Ships
Chlorhexidine gluconate 0.20% +	$31.1K	6
Each 100GM contains - pudinah ke phool	$29.5K	4
Kamagra jelly 100GM(act. qty.	$25.2K	2
Each tablet contains gliclazide 80MG	$22.6K	8
Each dose contains - salbutamol 100 MCG	$21.6K	6
Fourderm 20GM(act qty.19200x1x20gm	$21.5K	2
Hydroquinone (2% w/w) + mometasone	$19.4K	2
No scars cream(act. qty. 4032x20gm	$19.3K	2
Each tablet containscefuroxime 500MG	$18.9K	8
Salmeterol & fluticasone propionate	$16.3K	6
Amoxicillin + clavulanic acid 625MG	$16.2K	2
Azicip-500MG TAB(act qty.11520x1x3t	$15.0K	2
Kamagra gold 100tab(act. qty	$14.7K	1
Tinidazole (500MG) + clarithromycin	$13.9K	4
Glymat tabs(act qty.17500x1x10t)Each TAB	$13.3K	2

SSP International Services, imports 500 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Iodex	Brand Names & OTC Products	$28.8K	22	0.2%	9
2	Savlon	Brand Names & OTC Products	$3.4K	9	3.7%	6

SSP International Services, imports 2 pharmaceutical products across 1 categories into Guyana totaling $32.2K.

SSP International Services, — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

SSP International Services is a pharmaceutical importer and buyer based in Georgetown, Guyana. Operating from 264 Forshaw Street, Queenstown, Georgetown, the company specializes in sourcing finished pharmaceutical formulations from India. Their product portfolio primarily includes over-the-counter (OTC) and branded medications, with a focus on well-known products such as Iodex and Savlon. The company plays a significant role in the Guyanese pharmaceutical distribution network, ensuring the availability of essential medications to meet local demand.

2Distribution Network

While specific details about SSP International Services' warehouse locations and logistics capabilities are not publicly disclosed, their consistent import activities suggest a well-established distribution network within Guyana. The company's operations are likely centered in Georgetown, the capital city, which serves as the primary hub for pharmaceutical distribution in the country. Given the strategic location of Georgetown, SSP International Services is well-positioned to supply various regions across Guyana, ensuring timely delivery of pharmaceutical products to meet the needs of healthcare providers and consumers.

3Industry Role

SSP International Services functions as a primary wholesaler in Guyana's pharmaceutical supply chain. By importing finished pharmaceutical formulations from India, the company bridges the gap between international manufacturers and the local market. Their role is crucial in ensuring the steady availability of essential medications, thereby supporting the healthcare infrastructure in Guyana. Through their import activities, SSP International Services contributes to the diversification and stability of the pharmaceutical supply in the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — SSP International Services,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SSP International Services demonstrates a high level of supplier concentration, with 97.9% of their imports sourced from two Indian suppliers: Aashirwad Pharma International Private Limited and Aashirwad Exports. This significant reliance on a limited number of suppliers indicates a strategic choice to maintain consistent product quality and supply reliability. However, such concentration also poses potential risks, including vulnerability to supply chain disruptions or changes in supplier dynamics. The stability of this relationship is evidenced by the consistent volume of shipments over the years, suggesting a strong and dependable partnership between SSP International Services and their Indian suppliers.

2Supply Chain Resilience

The resilience of SSP International Services' supply chain is closely tied to the stability and reliability of their Indian suppliers. With a limited number of suppliers, the company may face challenges in mitigating risks associated with supply chain disruptions. The lack of publicly available information on backup suppliers and the diversity of formulations imported further underscores the need for strategic planning to enhance supply chain resilience. Ensuring compliance with international regulatory standards, such as those set by the World Health Organization (WHO), is essential for maintaining the quality and safety of imported pharmaceutical products.

Importing Pharmaceuticals into Guyana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Guyana

1Regulatory Authority & Framework

In Guyana, the Government Analyst - Food and Drug Department (GA-FDD) serves as the primary regulatory authority overseeing the importation, registration, and quality control of pharmaceutical products. The Food and Drugs Act (1971) and its associated regulations provide the legislative framework governing the importation and distribution of drugs within the country. These regulations ensure that all pharmaceutical products meet specific safety, efficacy, and quality standards before they are permitted for sale in the Guyanese market.

2Import Licensing & GMP

Importers of pharmaceutical products into Guyana are required to obtain an import license from the GA-FDD for each shipment. Additionally, all pharmaceutical drugs imported into Guyana must be registered with the GA-FDD, ensuring compliance with the Food and Drugs Act and its regulations. The GA-FDD relies on assessments from recognized reference authorities, such as the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO), to evaluate the safety, efficacy, and quality of pharmaceutical products. Importers must ensure that their products meet the standards set by these authorities to facilitate the registration process.

Quality & Labeling

SSP International Services, — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SSP International Services focuses on importing over-the-counter (OTC) and branded pharmaceutical products, with a notable emphasis on items like Iodex and Savlon. This strategic focus aligns with the market demand for accessible and trusted healthcare solutions in Guyana. The choice to import these specific therapeutic areas is driven by consumer preferences and the need for effective treatments for common ailments. By concentrating on these product categories, SSP International Services aims to meet the healthcare needs of the Guyanese population while ensuring the availability of high-quality pharmaceutical products.

2Sourcing Profile

SSP International Services primarily sources generic pharmaceutical products from India, focusing on finished formulations such as tablets, capsules, syrups, and injections. This sourcing strategy allows the company to offer a diverse range of medications to the Guyanese market. India's well-established pharmaceutical industry, known for its adherence to international quality standards, makes it a reliable source for these products. By importing finished formulations, SSP International Services can efficiently meet local demand without the complexities associated with sourcing raw active pharmaceutical ingredients (APIs).

3Market Positioning

Seller's Guide — How to Become a Supplier to SSP International Services,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Guyanese market through partnerships with SSP International Services. The company's existing focus on importing over-the-counter and branded pharmaceutical products indicates a potential for diversification in their product offerings. New suppliers can fill gaps in SSP International Services' current sourcing by providing additional products that meet the therapeutic needs of the Guyanese population. Establishing a relationship with SSP International Services would require ensuring compliance with Guyanese regulatory standards and demonstrating the quality and efficacy of the products offered.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to SSP International Services and the Guyanese market must ensure that their products are registered with the GA-FDD. This registration process involves providing comprehensive documentation, including certificates of analysis, stability data, and evidence of compliance with Good Manufacturing Practices (GMP). Labeling must be in English and include all necessary information as stipulated by the GA-FDD. Additionally, exporters should be prepared to undergo inspections and audits to verify compliance with regulatory standards.

Frequently Asked Questions — SSP International Services,

What products does SSP International Services, import from India?

SSP International Services, imports 2 pharmaceutical products across 1 categories. Top imports: Iodex ($28.8K), Savlon ($3.4K).

Who supplies pharmaceuticals to SSP International Services, from India?

SSP International Services, sources from 3 verified Indian suppliers. The primary supplier is Aashirwad Pharma International Private Limited (51.1% of imports, $660.7K).

What is SSP International Services,'s total pharmaceutical import value?

SSP International Services,'s total pharmaceutical import value from India is $32.2K, based on 31 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does SSP International Services, focus on?

SSP International Services, imports across 1 categories. The largest: Brand Names & OTC Products (100.0%).

Get Full SSP International Services, Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.